Asthma Attack
27
6
9
7
Key Insights
Highlights
Success Rate
88% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
3.7%
1 terminated out of 27 trials
87.5%
+1.0% vs benchmark
7%
2 trials in Phase 3/4
0%
0 of 7 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 7 completed trials
Clinical Trials (27)
Post Exacerbation Asthma Clinic Telecare Intervention to Reduce Recurrent Exacerbations
Cost Effective Air Filtration Intervention in Low-Income Housing to Reduce Asthma Morbidity
Boosting Referrals to Asthma Specialists for Patients Seen at the Emergency Room for an Asthma Exacerbation
Wearable Electronic Breath Sound Sensing Device
Remote Monitoring of Asthma in Children and Young People
The Effect of Asthma Flare-up Clinic After Exacerbation
Individualizing Treatment for Asthma in Primary Care (Full Study)
A Study to Assess the Effect of Dexpramipexole in Adolescents and Adults With Eosinophilic Asthma
Phenotyping and Classifying Asthma Exacerbations
Nebulized Ketamine Plus Standard Care vs. Standard Care Alone in Moderate to Severe Asthma Exacerbations
Remote Patient Monitoring Solution for Chronic Respiratory Disease Management
Timely Administration of IV Magnesium Sulfate in Patients With a Moderate Asthma Exacerbation
Pragmatic RCT of High-dose Oral Montelukast for Moderate and Severe Pediatric Acute Asthma Exacerbations
Using the Blood Eosinophil Count to Guide Systemic Corticosteroid Treatment in Asthma Exacerbations
ASTHMAXcel Emergency Department Study
The Use of Home Spirometry in the Monitoring of Patients With Acute Exacerbation of Asthma
Optimisation of ASthma In Those With Uncontrolled Symptoms (OASIS)
Nebulized Versus Intravenous Magnesium Sulfate in Treatment of Asthma Exacerbation
Asthma: Phenotyping Exacerbations 3
Genomics and Metagenomics of Asthma Severity